XTalks
OCTOBER 27, 2021
Genentech’s ocular implant drug delivery system for treatment of macular degeneration has received approval from the US Food and Drug Administration (FDA). Susvimo delivers ranibizumab via a port delivery system into a surgically placed implant in the eye, allowing for continuous delivery of the drug.
XTalks
AUGUST 30, 2022
Clinical research experts from the CRO Medpace shared insights about the operational and regulatory considerations for neuroscience trials with direct CNS administration. Vornov, the use of intrathecal delivery in drug development is unexplored for small molecules and peptides besides what has already been proved.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
JUNE 7, 2023
The additional investment will support growth of the company’s proprietary RALA platform with an immediate focus on the advancement of pHion’s lead project, PTX_V1, into clinical trials in the first half of 2024. PTX_V1 is a first-in-class therapeutic vaccine for the treatment of human papilloma virus (HPV)-related cancers.
XTalks
MAY 30, 2023
The healthcare industry has one of the heaviest environmental footprints, and manufacturers are increasingly faced with regulations to make more sustainable products,” said Mohammad H. There are also several ECG patches currently in clinical trials that could soon enter the market. Behfar, senior scientist at VTT, in the news release.
Pharmaceutical Technology
MARCH 22, 2023
The injectable drugs market is currently valued at around $532 billion. Yet while demand for injectables soars, regulators are cracking down on quality requirements, forcing many pharma companies to examine the role – and risks – of their primary packaging. Regulators are also paying close attention to the risks.
Expert insights. Personalized for you.
104 
Let's personalize your content